The Effect of Height on Adverse Short-Term Outcomes After Lower-Extremity Bypass Surgery in Patients with Diabetes Mellitus
Journal of the American Podiatric Medical Association · 2024
DOI: 10.7547/21-258 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, 2024. Verfasst von Kushkaran Kaur und 3 weiteren Autor:innen. Beteiligte Einrichtung: *Temple University Hospital Podiatric Surgical Residency Program, Philadelphia, PA. Hauptthemen laut MEDLINE: Body Height, Lower Extremity. Die Arbeit nennt 39 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
We evaluated adverse short-term outcomes after open lower-extremity bypass surgery in patients with diabetes mellitus with a comparison performed based on patient height.
Methods
The American College of Surgeons National Surgical Quality Improvement Program database was analyzed to select patients with Current Procedural Terminology codes 35533, 35540, 35556, 35558, 35565, 35566, 35570, and 35571 and with the diagnosis of diabetes mellitus. This resulted in 83 patients 60 inches or less in height, 1,084 between 60 and 72 inches, and 211 patients 72 inches and taller.
Results
No differences were observed among groups with respect to the development of a superficial surgical site infection (9.6% versus 6.4% versus 5.7%; P = .458), deep incisional infection (1.2% versus 1.4% versus 2.8%; P = .289), sepsis (2.4% versus 2.0% versus 2.8%; P = .751), unplanned reoperation (19.3% versus 15.6% versus 21.8%; P = .071), or unplanned hospital readmission (19.3% versus 14.8% versus 17.1%; P = .573). A significant difference was observed among groups in the development of a wound disruption (4.8% versus 1.3% versus 4.7%; P = .001). A multivariate regression analysis was performed of the wound disruption outcome with the variables of age, sex, race, ethnicity, height, weight, current smoker, and open wound/wound infection. Race ( P = .025) and weight ( P = .003) were found to be independently associated with wound disruption, but height was not ( P = .701).
Conclusions
The results of this investigation demonstrate no significant differences in short-term adverse outcomes after lower-extremity bypass surgery based on patient height.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- *Temple University Hospital Podiatric Surgical Residency Program, Philadelphia, PA.
- †Foot Care Center, Havertown, PA.
- ‡Department of Vascular Surgery, Temple University Hospital, Philadelphia, PA.
- §Department of Podiatric Surgery, Temple University School of Podiatric Medicine, Philadelphia, PA.
Zitieren
APA
Kaur, K., Cornell, R. S., Oresanya, L., & Meyr, A. J. (2024). The Effect of Height on Adverse Short-Term Outcomes After Lower-Extremity Bypass Surgery in Patients with Diabetes Mellitus. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/21-258
Vancouver
Kaur K, Cornell RS, Oresanya L, Meyr AJ. The Effect of Height on Adverse Short-Term Outcomes After Lower-Extremity Bypass Surgery in Patients with Diabetes Mellitus. Journal of the American Podiatric Medical Association. 2024. doi:10.7547/21-258
BibTeX
@article{Kaur2024,
author = {Kaur, Kushkaran and Cornell, Rhonda S and Oresanya, Lawrence and Meyr, Andrew J},
title = {The Effect of Height on Adverse Short-Term Outcomes After Lower-Extremity Bypass Surgery in Patients with Diabetes Mellitus},
journal = {Journal of the American Podiatric Medical Association},
year = {2024},
doi = {10.7547/21-258}
}
EUVIMED